The FDA Law Blog

MARCH 7, 2024

The new draft guidance is generally reflective of these developments, and we wanted to highlight several of the changes in this blog post. DMC charters have also grown longer and more detailed. The 2006 guidance noted that these would be “rare cases” limited to “specific issues of urgent concern.”

Documentation 105

Documentation FDA Adverse Reactions Communication 105

ISPE

MARCH 28, 2023

Wang Fang min, Chairman of Project and Alliance Management, Shanghai Pharmaceutical and Medical Device Adverse Reaction Monitoring Center；Ms. Lynn Wang, Head of Project and Alliance Management of Wuxi Bio；Ms. Zhang Nan, General Manager of Thermo Fisher Science and Technology; Ms. Shi Yun, QA Manager of Restone Biomedicine Co.,

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

ISPE

MARCH 28, 2023

2022 ISPE China Pharmaceutical Supply Chain Summit Trudy Patterson Tue, 03/28/2023 - 09:24 iSpeak Blog iSpeak 2022 ISPE China Pharmaceutical Supply Chain Summit 28 March 2023 On 17 December 2022, more than 100 people from all over the world gathered online for the 2022 ISPE China Pharmaceutical Supply Chain Summit. By Li Jie of ClinsChain

Adverse Reactions 52

Adverse Reactions Packaging Communication Labelling 52

PharmD Live

JANUARY 25, 2022

A pharmacist who can review the additional added medications and ensure no adverse reactions are expected, and no drug interactions considerably lowers the risk to this population. With a PharmD managing chronic care services, communication and knowledge sharing are facilitated between all providers. Back to Main Blog.

Adverse Reactions 52

Adverse Reactions Patient Care Communication Hospitals 52